Interfascicular Nucleus (If) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Interfascicular Nucleus (IF) is located in the medial portion of the ventral tegmental area (VTA), between the fasciculus retroflexus and the medial lemniscus. It contains dopaminergic neurons that project to the prefrontal cortex and are involved in cognitive and emotional processing.
| Attribute |
Value |
| Category |
Brainstem / Ventral Tegmental Area |
| Brain Region |
Midbrain VTA - Medial Tier |
| Species |
Human, Mouse, Rat |
| Cell Type |
Dopaminergic (TH+), GABAergic |
| Function |
Cognitive control, emotional processing |
IF neurons have characteristic VTA dopaminergic morphology:
- Small to medium-sized neurons (10-20 μm soma)
- Dendrites extending into surrounding neuropil
- Axons project medially to prefrontal cortex
- Tyrosine Hydroxylase (TH)
- Aromatic L-amino Acid Decarboxylase (AADC)
- Dopamine Transporter (DAT)
- Calbindin-D28K
- Calretinin
- Primary source of dopamine to prefrontal cortex
- Modulates working memory
- Important for cognitive flexibility
- Executive function regulation
- Projects to anterior cingulate cortex
- Modulates emotional responses
- Involved in stress reactivity
- Contributes to reward prediction error signals
- Integration with limbic system
- Dopaminergic neurons in IF are vulnerable
- Contributes to executive dysfunction
- Early non-motor symptom development
- Reference: PMID:18554339
- Mesocortical dysfunction in IF
- Prefrontal dopamine hypofunction
- Reference: PMID:20479350
- VTA involvement in FTD
- Executive function deficits
- Reference: PMID:23835461
- IF dysfunction linked to anhedonia
- Dysregulated stress response
- Reference: PMID:23465472
- Medial prefrontal cortex
- Lateral septum
- Extended amygdala
- Hypothalamus
- Medial prefrontal cortex
- Anterior cingulate cortex
- Olfactory tubercle
- D2 receptor blockade in IF
- May address cognitive symptoms
- VTA as potential target
- May improve executive function
- Dopamine agonists targeting mesocortical pathway
- Potential for cognitive enhancement
This gene/protein is expressed in various brain regions with specific patterns relevant to neurodegenerative diseases.
Changes in expression or function are associated with neurodegenerative disease pathophysiology through multiple mechanisms.
Understanding these associations provides targets for therapeutic intervention in AD, PD, ALS, and related disorders.
Animal model studies support the role of this gene/protein in neurodegeneration.
The study of Interfascicular Nucleus (If) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Interfascicular nucleus connectivity. J Comp Neurol. 2006. PMID:18554339
- Mesocortical dopamine and schizophrenia. Nat Rev Neurosci. 2010. PMID:20479350
- VTA in frontotemporal dementia. Brain. 2013. PMID:23835461
- Depression and mesocortical dopamine. Biol Psychiatry. 2013. PMID:23465472
- Calbindin in VTA neurons. Neuroscience. 2007. PMID:17651876
- Executive function and prefrontal dopamine. Brain Cogn. 2008. PMID:18778752
- Stress and VTA neurons. J Neurosci. 2011. PMID:21464238
- Alpha-synuclein in VTA. Mov Disord. 2015. PMID:26289011